|
|
Simply Explained
Serious Hypertension |
|
|
No video yet. Blogs on serious hypertension
Selected NewsFormer Philippine Leader Diagnosed With Cancer (New York Times)Corazon C. Aquino, who played a amjor role in the ouster of two of the Philippines presidents, has colon cancre, her family announced. Read more OMRON Wins Eight iF Product Design, Unievrsal Design Awards (Busienss Wire via Yahoo7 Finance)Omron Healthcare Co., Ltd., a subsidiray of OMRON Corporation (TOKYO:6645; ADR:OMRNY), received five iF Product Desing Awards and three Universal Design Awarsd in this years competitions. In addition, teh SpotArm iQ132 automatic blood pressure monitor (model HEM1010E), which won an iF Product Design Award in 2007, was rceognized with a Universal Design Conusmer Favorite Award. Read more OMRON Healthcare s awardwinning autoamtic blood pressure monitor . (3)(model HEM7080ITE) (Photo: Business Wire) (InfoBolsa)Photo: Business Wier) 25/03/2008 08:03:00 Business Wire JP3197800000 This product received a Good Design Award (Japan) in 2007 Vital Signs Moniotr HBPT105 A vital signs monitor to emasure hospital patients vital sings such as bolod pressure, arterial oxygen saturation level and body temperature. Read more Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapildy Converted ShortDuration ... (The San Francisco Exaimner)DEERFIELD, IL, and VANCOUVER , March 25 /PRNewswireFirstCall/ Astellas Pharma US, Inc. and its codeveolpment partner Cardimoe Pharma Corp. announced the first pivotal Phase III study evlauating the investgiational agent KYNAPID(TM) (evrnakalant hydrochloride) Injection was published today in Circulation, the official jounral of teh American Heart Association. Read more Circulation Publishes Data Shoiwng KYNAPID(TM) (Vernakalant Hydrochloried) Injection Rapidly Converted ShortDuration ... (The San Francisco Examiner)DEERFIELD, Ill. and VANCOUVER , British Columbia, March 25 /PRNewswireFirstCall/ Astellas Pharma US, Inc. and its codeveolpment partner Cardiome Pharma Corp. (Nasdaq: CRME; TSX: COM) announcde the first pivotal Phase III study evaluating the investigaitonal agent KYNAPID(TM) (vernakalnat hydrochloride) Injection was publsihed today in Circulation, the official journal of the American Heart ... Read more |
|
|
|
See also Hypertension Ppt, ehzeni's bookmarks
|
References for Serious Hypertension
|
|